Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Assisted Reproduction and Genetics
Erschienen in: Journal of Assisted Reproduction and Genetics 8/2011

01.08.2011 | Opinion

“Premature luteinization” in the era of GnRH analogue protocols: time to reconsider

verfasst von: Johnny S. Younis

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Excerpt

The introduction of the GnRH analogues and their employment into the routine practice of controlled ovarian hyperstimulation (COH) for assisted reproductive technologies (ART) was expected to abolish premature LH and consequently follicular progesterone (P) elevations. More than two decades have passed since the GnRH agonist was brought into practice and more than one decade since the GnRH antagonist was commenced, however moderate P elevation, before the day of hCG administration, is continuing to complicate a significant part of ART cycles employing both protocols, ranging from 12.4 to 52.3% [1]. …
Literatur
1.
Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systemic review and meta-analysis. Hum Reprod Update. 2007;13:343–55.PubMedCrossRef
2.
Bosch E, Labarta E, Crespo J, Simon C, Remohí, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25:2092–100.PubMedCrossRef
3.
Fleming R, Jenkins J. The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles. Reprod Biomed Online. 2010;21:446–9.PubMedCrossRef
4.
Younis J, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril. 1996;66:873–84.PubMed
5.
Messinis IE, Templeton A, Baird DT. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin. J Clin Endocrinol Metab. 1985;61:1076–80.PubMedCrossRef
6.
Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985;92:85–93.
7.
Lujueune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril. 1986;45:377–83.
8.
Eibschitz I, Belaisch-Allart JC, Frydman R. In vitro fertilization management and results in stimulated cycles with a spontaneous luteinizing hormone discharge. Fertil Steril. 1986;45:231–6.PubMed
9.
Hofmann GE, Bergh PA, Guzman I, Masuku S, Navot D. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Fertil Steril. 1993;8:695–8.
10.
Younis JS, Matilsky M, Radin O, Ben-Ami M. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization—embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril. 2001;76:294–9.PubMedCrossRef
11.
Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotrophin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80:1444–9.PubMedCrossRef
12.
Adonakis G, Deshpande N, Yates RWS, Fleming R. luteinization hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotrophin-releasing hormone agonist and follicle-stimulating hormone. Fertil Steril. 1998;69:450–53.PubMedCrossRef
13.
Filicori M, Cognogni GE, Pocognoli E, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotropin administration. Hum Reprod. 2002;17:2009–15.PubMedCrossRef
14.
Filicori M, Cognogni GE, Pocognoli P, et al. Comparison of controlled ovarian stimulation with human menopausal gonadotrophin or recombinant follicle-stimulating hormone. Fertil Steril. 2003;80:390–7.PubMedCrossRef
15.
Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril. 1996;66:275–80.PubMed
16.
Andersen AN, Devroey P, Arce JC, MERIT Group. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217–27.PubMedCrossRef
17.
Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE. Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil Steril. 1995;63:1267–71.PubMed
18.
19.
Younis JS. Elevated progesterone level on the day of hCG administration is related to FSH dose: is it all the truth? Hum Reprod. 2011;26:498–9. Epub 2010 Dec 15.PubMedCrossRef
20.
De Ziegler D, Bijaoui G, Chapron C. Pre-hCG elevation of plasma progesterone; good, bad or otherwise. Hum Reprod Update. 2008;14:393. Epub 2008 Jun 2.PubMedCrossRef
21.
Levran D, Ben-Shlomo I, Parientte C, Dor J, Mashiach S, Weissman A. Familial partial 17,20 desmolase and 17-hydroxylase deficiency presenting as infertility. J Assist Reprod Genet. 2003;20:21–7.PubMedCrossRef
22.
De Ziegler D, Brioschi PA, Fanchin R, Bulleti C. Confronting the hidden face of progesterone during the follicular phase. J Assist Reprod Genet. 2003;20:29–32.PubMedCrossRef
23.
Bosch E. Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007). Hum Reprod Update. 2008;14:194–5.PubMedCrossRef
24.
Younis JS, Haddad S, Matilsky M, Ben-Ami M. Premature luteinization: could it be an early manifestation of low ovarian reserve? Fertil Steril. 1998;69:461–5.PubMedCrossRef
25.
Fleming R. Progesterone elevation on the day of hCG: methodological issues. Hum Reprod Update. 2008;14:391–3.PubMedCrossRef
Metadaten
Titel
“Premature luteinization” in the era of GnRH analogue protocols: time to reconsider
verfasst von
Johnny S. Younis
Publikationsdatum
01.08.2011
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 8/2011
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-011-9585-x

Weitere Artikel der Ausgabe 8/2011

Journal of Assisted Reproduction and Genetics 8/2011 Zur Ausgabe

Genetics

An association study of SPO11 gene single nucleotide polymorphisms with idiopathic male infertility in Chinese Han population

Stem cell biology

Derivation of buffalo embryonic stem-like cells from in vitro-produced blastocysts on homologous and heterologous feeder cells

Technical Innovations

Digital holographic microscopy in human sperm imaging

Case Report

The follicular stigma—a window for better understanding of ovulation

Genetics

Single nucleotide polymorphism in the UBR2 gene may be a genetic risk factor for Japanese patients with azoospermia by meiotic arrest

Technical Innovations

A potential use of embryonic stem cell medium for the in vitro culture of preimplantation embryos

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise